MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    A Rare Manifestation of Oculogyric Crisis in Schizophrenia Patients with Risperidone: Case Series

    D. Siregar, D. Tunjungsari, A. Tiksnadi, E. Hanafi (Jakarta Pusat, Indonesia)

    Objective: To describe two cases of oculogyric crisis caused by risperidone Background: The oculogyric crisis (OGC) is an acute dystonic movement disorder of the eye,…
  • 2024 International Congress

    Conceptualization of the MDS Parkinson’s Disease Psychosis Rating Scale (MDS-PDPRS) prototype.

    M. Tosin, T. Mestre, G. Stebbins, G. Mangone, S. Videmsky, S. Ali, D. Aarsland, J. Goldman, T. Khoo, S. Lewis, P. Martinez-Martin, O. Ojo, J. Pagonabarraga, A. Schrag, D. Weintraub, C. Goetz (Chicago, USA)

    Objective: To outline the process of conceptualizing the prototype for the International Parkinson and Movement Disorder Society Parkinson's Disease Psychosis Rating Scale (MDS-PDPRS). Background: Approximately…
  • 2024 International Congress

    Reliability and Validity of the English Version of the Parkinson Anxiety Scale

    J. Lam, X. Tang, D. Meng, P. Uzelman, F. Pio, N. Ainsworth, F. Vila-Rodriguez, S. Appel-Cresswell (Vancouver, Canada)

    Objective: To evaluate the reliability and validity of the English version of the Parkinson Anxiety Scale (PAS) in patients with Parkinson’s disease (PD). Background: The…
  • 2024 International Congress

    Gender Differences in Physical Activity in Parkinson’s Disease

    G. Vitek, M. Fullard (Aurora, USA)

    Objective: Examine gender differences in physical activity in different stages of Parkinson’s disease (PD). Background: Physical activity has been linked to slower progression and improvement…
  • 2024 International Congress

    Association between Non-Motor Parkinson’s disease symptoms and hyposmia in a population-based cohort

    C. Theyer, K. Marini, F. Krismer, C. Horlings, H. Stockner, K. Schwarzová, I. Egner, A. Djamshidian-Tehrani, M. Marti, R. Krüger, V. Satagopam, B. Mollenhauer, S. Schade, C. Trenkwalder, K. Rege, S. Ghosh, A. Garrido, E. Tolosa, T. Marques, D. Mcintyre, W. Poewe, K. Seppi, P. Mahlknecht (Innsbruck, Austria)

    Objective: To describe the association between different Parkinson’s disease (PD) related non-motor symptoms (NMS) and hyposmia in a population-based cohort. Background: Olfactory dysfunction is of…
  • 2024 International Congress

    Increased Resting Anterior Hippocampus Metabolism and Hippocampus Subfields Structural Abnormalities in Functional Tremor Patients: FDG- PET Study and Volumetric MRI Study

    M. Ahmed, P. Dupont, S. Du Plessis, J. Warwick, A. Doruyter, E. Lee Pan, J. Carr (Cape Town, South Africa)

    Objective: In this study, we focused on identifying the resting 18F-FDG PET brain imaging patterns in the limbic region and measuring the MRI volumes of…
  • 2024 International Congress

    Correlation of Clinical Rating Scale for Tremor with Global Assessment

    S. Howard, S. Singh, D. Macaluso, J. Hsu, I. Cajigas, L. Qiu, C. Halpern, W. Aamodt, J. Farrar (Philadelphia, USA)

    Objective: Objective: The objective was to determine the association of the Fahn-Tolosa-Marin Clinical Rating Scale for Tremor (CRST) scores with the CRST global assessment. Background:…
  • 2024 International Congress

    Altered activity of lysosomal hydrolases in monocyte-derived macrophages as potential biomarker for differential diagnosis of multiple system atrophy

    K. Basharova, A. Bezrukova, G. Baydakova, I. Miliukhina, E. Zakharova, S. Pchelina, T. Usenko (Gatchina, Russian Federation)

    Objective: The aim was to assess the possibility of differentiating synucleinopathies (Parkinson’s disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA) by lysosomal…
  • 2024 International Congress

    Cohort effects on risk scores and risk markers for Parkinson’s disease – comparison of an online-recruited versus population-based cohort

    K. Marini, C. Theyer, C. Horlings, H. Stockner, K. Schwarzová, I. Egner, A. Djamshidian-Tehrani, G. Rungger, P. Willeit, J. Willeit, S. Kiechl, M. Martì, A. Garrido, E. Tolosa, B. Mollenhauer, C. Trenkwalder, S. Schade, R. Krüger, V. Satagopam, K. Rege, S. Ghosh, T. Marques, D. Mcintyre, K. Seppi, W. Poewe, P. Mahlknecht (Innsbruck, Austria)

    Objective: To compare the distribution of Parkinson’s disease (PD) risk markers and comprehensive risk scores in an online-cohort recruited with open invitations through a media…
  • 2024 International Congress

    Disparities in Botulinum Toxin Utilization for Cervical Dystonia in a United States Medicare Population

    M. Verduzco-Gutierrez, A. Keener, I. Howard, D. Torres-Russotto, J. Sparrow, R. Kazerooni (San Antonio, USA)

    Objective: To examine the disparities in utilization of botulinum toxin (BoNT) injections for patients with cervical dystonia (CD) within the United States Medicare population. Background:…
  • « Previous Page
  • 1
  • …
  • 121
  • 122
  • 123
  • 124
  • 125
  • …
  • 1554
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25128 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley